Submitted by fdagov3951 in business
Lenmeldy is the first FDA-approved gene therapy to treat children with metachromatic leukodystrophy (MLD).
Submitted by fdagov3951 in business
Lenmeldy is the first FDA-approved gene therapy to treat children with metachromatic leukodystrophy (MLD).